Русский
Delayed-release drugs for the treatment of knee osteoarthritis – drugs of choice in a comorbid patient
DOI: https://dx.doi.org/10.18565/pharmateca.2023.1-2.182-187
D.Yu. Andriyashkina, A.A. Klimenko, N.A. Demidova, A.A. Kondrashov, M.O. Anischenko
Department of Faculty Therapy n.a. Academican A.I. Nesterov, Faculty of General Medicine, Pirogov Russian National Research Medical University, Moscow, Russia
Osteoarthritis is the most common joint disease in adults. Statistical data allow to talk about a constant increase in the number of patients suffering from this disease. Despite progress in understanding the pathogenesis of the disease, osteoarthritis remains an incurable pathology. Additional difficulties may arise in the presence of concomitant pathology in a patient, limiting the intake, in particular, of non-steroidal anti-inflammatory drugs. The article presents modern approaches to the treatment of osteoarthritis, as well as clinical observation of a patient with comorbid pathology and the use of a delayed-release drug for its treatment.
Keywords: delayed-release drugs, local injection therapy, comorbid patient, hyaluronic acid, knee joint, glucosamine, chondroitin sulfate, osteoarthritis, non-steroidal anti-inflammatory drugs
About the Autors
Corresponding author: Daria Yu. Andriyashkina, Cand. Sci. (Med.), Associate Professor at the Department of Faculty Therapy n.a. Acad. A.I. Nesterov, Faculty of General Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; andryashkina.darya@yandex.ru; ORCID:
https://orcid.org/0000-0001-8266-6022 , elibrary SPIN: 1804-1274
Similar Articles
